Clinical Trial Update: The Effect of Alendronate on the Immune Response to Hepatitis B Vaccine in Healthy Adults [Phase 1]

View source ↗

Summary

Phase 1 study examining whether alendronate affects the immune response to the Hepatitis B vaccine in healthy adults has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatitis B

Drugs mentioned

• alendronate (alendronate)

Snippet

Sponsor: Massachusetts General Hospital | Conditions: Hepatitis B | Phase 1 | Status: COMPLETED